Detail akcie Pharmena online

Business Summary: Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Pharmena SA revenues decreased 94% to PLN10K. Net income before extraordinary items totaled PLN235K vs. loss of PLN1.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net Income reflects Total Financial Income increase from PLN0K to PLN468K (income), Total Financial Expense decrease of 90% to PLN24K (expense).